Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 22.04B | 17.54B | 25.29B | 20.50B | 12.42B |
Gross Profit | 7.41B | 5.33B | 8.48B | 6.64B | 4.47B |
EBITDA | 2.97B | 1.75B | 4.04B | 2.84B | 1.67B |
Net Income | 964.91M | -72.80M | 2.29B | 1.57B | 707.17M |
Balance Sheet | |||||
Total Assets | 46.39B | 42.95B | 39.51B | 35.13B | 29.85B |
Cash, Cash Equivalents and Short-Term Investments | 9.46B | 9.03B | 9.53B | 9.77B | 8.66B |
Total Debt | 6.74B | 8.01B | 5.28B | 5.22B | 4.89B |
Total Liabilities | 12.75B | 12.35B | 10.31B | 9.77B | 7.78B |
Stockholders Equity | 32.48B | 29.61B | 28.30B | 24.60B | 21.38B |
Cash Flow | |||||
Free Cash Flow | 1.40B | -1.85B | 213.32M | 1.12B | 1.79B |
Operating Cash Flow | 2.44B | 765.57M | 1.86B | 1.88B | 2.26B |
Investing Cash Flow | -1.64B | -3.30B | -1.88B | -432.10M | 643.39M |
Financing Cash Flow | -1.52B | 1.30B | -1.18B | -673.55M | -145.99M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥14.31B | 14.97 | 1.91% | 2.63% | 268.28% | ||
80 Outperform | ¥18.28B | 10.43 | 1.95% | 20.91% | 18.64% | ||
76 Outperform | ¥14.27B | 14.78 | 2.08% | 25.64% | ― | ||
71 Outperform | ¥13.34B | 10.56 | 3.55% | -6.96% | -1.72% | ||
65 Neutral | ¥12.92B | 16.76 | 1.91% | 25.48% | ― | ||
65 Neutral | $10.84B | 16.29 | 5.52% | 2.09% | 3.14% | -29.96% | |
54 Neutral | ¥13.21B | ― | 5.43% | -1.14% | 68.17% |